1-3 of 3
Keywords: Non-seminoma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence and Clinical Features of Inguinal Metastases of Testicular Germ-Cell Tumors

Available to Purchase
Subject Area:
Further Areas
Markus Angerer, Henrik Zecha, Christian Wülfing, Klaus Peter Dieckmann
Journal: Urologia Internationalis
Urol Int (2025) 109 (3): 299–306.
https://doi.org/10.1159/000542431
Published Online: 06 January 2025
... to in the content or advertisements. 2025 Testicular cancer Germ cell tumors Seminoma Non-seminoma Groin Inguinal metastases Lymph node dissection Approximately 50% of non-seminomatous (NS) germ-cell tumors (GCTs) have metastases at the time of initial presentation, while the frequency...
View article titled, Incidence and Clinical Features of Inguinal Metastases of Testicular Germ-Cell Tumors
Open the PDF for Incidence and Clinical Features of Inguinal Metastases of Testicular Germ-Cell Tumors in another window
Journal Articles

Thirty-Year-Old Male Patient with Non-Seminoma and Coincidental Rectal Cancer

Open Access
Subject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates) , Karger e-Journal Backfile Collection 2023 , Further Areas
Julia Nolting, Desiree Louise Dräger, Oliver W. Hakenberg, Laila Schneidewind
Journal: Urologia Internationalis
Urol Int (2023) 107 (4): 429–432.
https://doi.org/10.1159/000528320
Published Online: 02 May 2023
...Julia Nolting; Desiree Louise Dräger; Oliver W. Hakenberg; Laila Schneidewind We present the case of a 31-year-old male patient with non-seminoma (90% embryonal carcinoma, 10% teratoma) pT1b L1 V0 Pn0 R0 cN2 cM0, Clinical Stage IIb and “good prognosis group” according to IGCCCG of the left testis...
View article titled, Thirty-Year-Old Male Patient with Non-Seminoma and Coincidental Rectal Cancer
Open the PDF for Thirty-Year-Old Male Patient with Non-Seminoma and Coincidental Rectal Cancer in another window
Journal Articles

Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II – Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy

Open Access
Subject Area:
Further Areas
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, Clemens Aigner, Walter Albrecht, Jens Bedke, Matthias Beintker, Dirk Beyersdorff, Carsten Bokemeyer, Jonas Busch, Johannes Classen, Maike de Wit, Klaus-Peter Dieckmann, Thorsten Diemer, Anette Dieing, Matthias Gockel, Bernt Göckel-Beining, Oliver W. Hakenberg, Axel Heidenreich, Julia Heinzelbecker, Kathleen Herkommer, Thomas Hermanns, Sascha Kaufmann, Marko Kornmann, Jörg Kotzerke, Susanne Krege, Glen Kristiansen, Anja Lorch, Arndt-Christian Müller, Karin Oechsle, Timur Ohloff, Christoph Oing, Ulrich Otto, David Pfister, Renate Pichler, Heinrich Recken, Oliver Rick, Yvonne Rudolph, Christian Ruf, Joachim Schirren, Hans Schmelz, Heinz Schmidberger, Mark Schrader, Stefan Schweyer, Stefanie Seeling, Rainer Souchon, Christian Winter, Christian Wittekind, Friedemann Zengerling, D.H. Zermann, Roger Zillmann, Peter Albers
Journal: Urologia Internationalis
Urol Int (2021) 105 (3-4): 181–191.
https://doi.org/10.1159/000511245
Published Online: 22 January 2021
... marker-negative non-seminomatous cSIIA GCT should be monitored first (serum tumour marker monitoring, repeat imaging after 6–8 weeks) or, alternatively, a diagnostic RPLND should be performed (B, 2b) [e7, e8]. Germ cell tumour of the testes Seminoma Non-seminoma Metastasis Extragonadal tumours...
View article titled, Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II – Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy
Open the PDF for Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II – Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy in another window